Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

Reduced GABAergic Action in the Autistic Brain

(2016) Caroline E. Robertson et al.   CURRENT BIOLOGY

Considerations in biomarker development for neurodevelopmental disorders

(2016) James C. McPartland   CURRENT OPINION IN NEUROLOGY

Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis

(2016) L. K. Fung et al.   PEDIATRICS

Genetics and genomics of autism spectrum disorder: embracing complexity

(2015) Silvia De Rubeis et al.   HUMAN MOLECULAR GENETICS

Autism Spectrum Disorder and Epilepsy

(2015) Shafali Spurling Jeste et al.   JOURNAL OF CHILD NEUROLOGY

Excess of rare, inherited truncating mutations in autism

(2015) Niklas Krumm et al.   NATURE GENETICS

Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci

(2015) Stephan J. Sanders et al.   NEURON

The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders

(2015) Sien Braat et al.   NEURON

GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism

(2015) J L Silverman et al.   NEUROPSYCHOPHARMACOLOGY

Inhibition-Based Biomarkers for Autism Spectrum Disorder

(2015) April R. Levin et al.   Neurotherapeutics

Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis

(2015) A Masi et al.   Translational Psychiatry

Disentangling the heterogeneity of autism spectrum disorder through genetic findings

(2014) Shafali S. Jeste et al.   Nature Reviews Neurology

Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders

(2013) E M Kenny et al.   MOLECULAR PSYCHIATRY

GABA estimation in the brains of children on the autism spectrum: Measurement precision and regional cortical variation

(2013) W. Gaetz et al.   NEUROIMAGE

Placebo effects in children: a review

(2013) Katja Weimer et al.   PEDIATRIC RESEARCH

Biomarkers in autism spectrum disorder: the old and the new

(2013) Barbara Ruggeri et al.   PSYCHOPHARMACOLOGY

Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function

(2012) Hyejung Won et al.   NATURE

Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations

(2012) Brian J. O’Roak et al.   NATURE

Postsecondary Education and Employment Among Youth With an Autism Spectrum Disorder

(2012) P. T. Shattuck et al.   PEDIATRICS

Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen

(2012) C. Henderson et al.   Science Translational Medicine

GABAB-mediated rescue of altered excitatory–inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction

(2012) M J Gandal et al.   Translational Psychiatry

Neocortical excitation/inhibition balance in information processing and social dysfunction

(2011) Ofer Yizhar et al.   NATURE

A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders

(2011) M. L. McPheeters et al.   PEDIATRICS

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

(2009) Bryan H. King et al.   ARCHIVES OF GENERAL PSYCHIATRY

Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model

(2009) G. Dawson et al.   PEDIATRICS

Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila

(2008) Shuang Chang et al.   Nature Chemical Biology